Proliferation-competent Tcf1+ CD8 T cells in dysfunctional populations are CD4 T cell help independent.
Animals
CD4-Positive T-Lymphocytes
/ cytology
CD8-Positive T-Lymphocytes
/ cytology
Cell Differentiation
/ immunology
Cell Movement
Cell Proliferation
Cells, Cultured
Epitopes, T-Lymphocyte
/ immunology
Hepatocyte Nuclear Factor 1-alpha
/ metabolism
Lymphocyte Activation
/ immunology
Mice
Mice, Transgenic
Phenotype
Signal Transduction
CD4 help
CD8 T cells
Tcf1
chronic infection
single-cell RNA sequencing
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
01 10 2019
01 10 2019
Historique:
pubmed:
19
9
2019
medline:
31
3
2020
entrez:
19
9
2019
Statut:
ppublish
Résumé
T cell maintenance in chronic infection and cancer follows a hierarchical order. Short-lived effector CD8 T cells are constitutively replaced from a proliferation-competent Tcf1-expressing progenitor population. This occurs spontaneously at low levels and increases in magnitude upon blocking PD-1 signaling. We explore how CD4 T cell help controls transition and survival of the progenitors and their progeny by utilizing single-cell RNA sequencing. Unexpectedly, absence of CD4 help caused reductions in cell numbers only among terminally differentiated cells while proliferation-competent progenitor cells remained unaffected with regard to their numbers and their overall phenotype. In fact, upon restoration of a functional CD4 compartment, the progenitors began to regenerate the effector CD8 T cells. Thus, unlike memory T cells for which secondary expansion requires CD4 T cell help, this is not a necessity for proliferation-competent progenitor cells in dysfunctional populations. Our data therefore reveals that proliferation-competent cells in dysfunctional populations show a previously unrecognized uncoupling of CD4 T cell help that is otherwise required by conventional memory T cells.
Identifiants
pubmed: 31530725
pii: 1902701116
doi: 10.1073/pnas.1902701116
pmc: PMC6778176
doi:
Substances chimiques
Epitopes, T-Lymphocyte
0
HNF1A protein, human
0
Hepatocyte Nuclear Factor 1-alpha
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20070-20076Subventions
Organisme : European Research Council
ID : 337043
Pays : International
Organisme : European Research Council
ID : 772473
Pays : International
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Exp Med. 2018 Oct 1;215(10):2520-2535
pubmed: 30154266
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
J Virol. 1994 Dec;68(12):8056-63
pubmed: 7966595
Curr Opin HIV AIDS. 2011 May;6(3):174-80
pubmed: 21502921
Immunity. 2016 Aug 16;45(2):415-27
pubmed: 27533016
Nature. 2006 Jul 20;442(7100):299-302
pubmed: 16855590
J Leukoc Biol. 2009 Aug;86(2):251-9
pubmed: 19401396
Nat Immunol. 2014 Dec;15(12):1104-15
pubmed: 25396352
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20070-20076
pubmed: 31530725
PLoS Pathog. 2014 Sep 25;10(9):e1004380
pubmed: 25255144
Cell. 2009 Jul 10;138(1):30-50
pubmed: 19596234
Nat Commun. 2017 May 03;8:15050
pubmed: 28466857
Immunity. 2010 Aug 27;33(2):229-40
pubmed: 20727791
Nat Immunol. 2004 Sep;5(9):927-33
pubmed: 15300249
J Immunol. 2017 Aug 1;199(3):911-919
pubmed: 28652395
Hepatology. 2010 Dec;52(6):1934-47
pubmed: 21064032
J Exp Med. 2016 Aug 22;213(9):1819-34
pubmed: 27455951
Nature. 2016 Sep 15;537(7620):417-421
pubmed: 27501248
For Immunopathol Dis Therap. 2015;6(1-2):7-17
pubmed: 28286692
Annu Rev Immunol. 2007;25:171-92
pubmed: 17129182
J Virol. 1994 Jul;68(7):4700-4
pubmed: 7911534
Gut. 2012 Aug;61(8):1226-34
pubmed: 21873736
Nature. 2004 Jan 22;427(6972):355-60
pubmed: 14737169
Nature. 2003 Feb 20;421(6925):852-6
pubmed: 12594515
Science. 2012 Nov 30;338(6111):1220-5
pubmed: 23197535
Science. 2003 Apr 11;300(5617):337-9
pubmed: 12690201
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
J Immunol. 2004 Apr 1;172(7):4204-14
pubmed: 15034033
J Biomed Biotechnol. 2011;2011:451694
pubmed: 21960736
Front Immunol. 2013 May 13;4:105
pubmed: 23717308
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419